
Tanja Gonska
Hospital Positions
Staff Physician, Division of Gastroenterology, Hepatology and Nutrition
Research Positions
Senior Associate Scientist, Translational Medicine
Learning Positions
Associate Member, Institute of Medical Sciences
Biography
Dr. Tanja Gonska is a Professor in the Division of Paediatric Gastroenterology, Hepatology and Nutrition, University of Toronto, with a subspecialty focus on paediatric pancreas diseases and cystic fibrosis. She holds appointments in the Institute of Medical Science and as a Senior Associate Scientist in the SickKids Research Institute. Following medical school in Muenster, Germany, she completed her paediatric residency training at the Children’s Hospital in Freiburg, Germany, with a focus on paediatric pulmonology, allergology and cystic fibrosis. Attracted by the renowned cystic fibrosis (CF) group, she came to Toronto for a fellowship in paediatric gastroenterology, hepatology and nutrition at SickKids. Her mentors were Professors Peter Durie, Christine Bear and Paul Quinton.
Dr. Gonska continued her academic career in paediatric pancreatology and cystic fibrosis as a Staff Physician at SickKids. Next to her involvement in an international consortium to advance the knowledge in paediatric pancreatitis, her main research interest is focused on increasing our understanding of transepithelial ion and fluid transport in the airway and intestine. In addition, her innovative approach to develop new measures of functional outcome supports current strategies to cure cystic fibrosis.
Publications
- Birimberg-Schwartz L, Ip W, Bartlett C, Avolio J, Vonk AM, Gunawardena T, Du K, Esmaeili M, Beekman JM, Rommens J, Strug L, Bear CE, Moraes TJ, Gonska T. Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis. Life Sci Alliance. 2023 Apr 5;6(6): e202201857.
- Sermet-Gaudelus I, Girodon E, Vermeulen F, Solomon GM, Melotti P, Graeber SY, Bronsveld I, Rowe SM, Wilschanski M, Tümmler B, Cutting GR, Gonska T. ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction. J Cyst Fibros. 2022 Nov;21(6):922-936.
- Gonska T, Keenan K, Au J, Dupuis A, Chilvers MA, Burgess C, Bjornson C, Fairservice L, Brusky J, Kherani T, Jober A, Kosteniuk L, Price A, Itterman J, Morgan L, Mateos-Corral D, Hughes D, Donnelly C, Smith MJ, Iqbal S, Arpin J, Reisman J, Hammel J, van Wylick R, Derynck M, Henderson N, Solomon M, Ratjen F. Outcomes of Cystic Fibrosis Screening-Positive Infants with Inconclusive Diagnosis at School Age. Pediatrics. 2021 Dec 1;148(6): e2021051740.
- Laselva O, Bartlett C, Gunawardena TNA, Ouyang H, Eckford PDW, Moraes TJ, Bear CE, Gonska T. Rescue of multiple class II CFTR mutations by elexacaftor+ tezacaftor+ivacaftor mediated in part by the dual activities of Elexacaftor as both corrector and potentiator. Eur Respir J. 2021 Jun 17;57(6):2002774.
- Ahmadi S, Wu YS, Li M, Ip W, Lloyd-Kuzik A, Di Paola M, Du K, Xia S, Lew A, Bozoky Z, Forman-Kay J, Bear CE, Gonska T. Augmentation of CFTR function in human bronchial epithelial cells via SLC6A14-dependent amino acid uptake: Implications for treatment of Cystic Fibrosis. Am J Respir Cell Mol Biol. 2019 Dec;61(6):755-764.
Please visit PubMed for a full list of Dr. Gonska's publications.